The document 'Follow the Pill: Understanding the U.S. Commercial Pharmaceutical Supply Chain' has been deleted

Related Documents

240 p.
Add to your reading list

US Federal Trade Commission: 10 Schmidt Pharmacy benefit managers

Federal Trade Commission DEBORAH PLATT MAJORAS THOMAS B. LEARY PAMELA JONES HARBOUR JON LEIBOWITZ Chairman Commissioner Commissioner Commissioner Maryanne Kane Charles H. Schneider Susan A. Creig...
  • ftc published this 01 / 20 / 2008
  • 279 reads
  • 0 comments
75 p.
Add to your reading list

[ Untitled ]

An Employer’s Guide to Pharmaceutical Benefits ACKNOWLEDGEMENTS T his project was conceived during the September, 2001 meeting of WRGH, as we wrestled with the challenges of the “pharmaceutical...
  • NPCNOW published this 11 / 04 / 2008
  • 442 reads
  • 0 comments
31 p.
Add to your reading list

The Basics and Industry Overview

PBMs: The Basics and an Industry Overview John Richardson The Health Strategies Consultancy, LLC June 26, 2003 1 Agenda 1. Basics of PBMs 2. Snapshot of PBM Industry Today 3. How PBMs Work: PBM...
  • api_user_11797_into_abyss published this 10 / 18 / 2008
  • 475 reads
  • 0 comments
36 p.
Add to your reading list

Health and Human Services: c3

CHAPTER 3 PRESCRIPTION DRUG PRICES One of the charges of this study was to examine the differences in drug prices paid by people with and without prescription drug coverage. Prices and price differ...
  • HHS published this 01 / 29 / 2008
  • 21 reads
  • 0 comments
36 p.
Add to your reading list

Health and Human Services: c3

CHAPTER 3 PRESCRIPTION DRUG PRICES One of the charges of this study was to examine the differences in drug prices paid by people with and without prescription drug coverage. Prices and price differ...
  • HHS published this 01 / 29 / 2008
  • 27 reads
  • 0 comments
17 p.
Add to your reading list

US Federal Trade Commission: V060018

UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION WASHINGTON, D.C. 20580 Office of Policy Planning Bureau of Economics Bureau of Competition October 2, 2006 Terry G. Kilgore, Member Commonwealt...
  • ftc published this 01 / 20 / 2008
  • 16 reads
  • 0 comments
70 p.
Add to your reading list

Pharmaceutical Benefit Design: Helping Employers Understand, Assess, Select and Manage Pharmacy Bene

This guide, produced by the National Business Group on Health’s Pharmaceutical Council, is designed to educate employers on pharmaceutical benefit design – to deepen understanding and simplify deci...
  • NPCNOW published this 11 / 05 / 2008
  • 987 reads
  • 0 comments
32 p.
Add to your reading list

US Federal Trade Commission: 2000--Competition%20in%20 the%20Pharmaceutical

For Official Use Organisation de Coopération et de Développement Economiques Organisation for Economic Co-operation and Development DAFFE/CLP/WP2/WD(2000)31 OLIS : 02-Jun-2000 Dist. : 06-Jun-2000...
  • ftc published this 01 / 20 / 2008
  • 77 reads
  • 0 comments
13 p.
Add to your reading list

US Federal Trade Commission: V040027

UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION Washington, DC 20580 Bureau of Competition Bureau of Economics Office of Policy Planning September 7, 2004 Assembly Member Greg Aghazarian Stat...
  • ftc published this 01 / 20 / 2008
  • 34 reads
  • 0 comments
45 p.
Add to your reading list

Health and Human Services: 60700107

Page 2 – Kerry Weems We recommend that Congress and CMS consider the results of our review, including the data provided, in any deliberations regarding Medicare Part D reimbursement. In its writt...
  • HHS published this 01 / 30 / 2008
  • 39 reads
  • 0 comments
53 p.
Add to your reading list

Health and Human Services: hcimu11003

HEALTH CARE INDUSTRY MARKET UPDATE Pharmaceuticals January 10, 2003 Dear Friends of CMS: As the regulators of over $500 billion per year of Medicare, Medicaid, and S-CHIP funds, we believe it is ...
  • HHS published this 01 / 30 / 2008
  • 351 reads
  • 0 comments
11 p.
Add to your reading list

Health and Human Services: 020907tmy

Testimony Before the House Oversight and Government Reform Committee u.s. House of Representatives "Allegations of Waste, Fraud and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal ...
  • HHS published this 01 / 30 / 2008
  • 22 reads
  • 0 comments
19 p.
Add to your reading list

pjay

Confidentiality Agreement The undersigned reader acknowledges that the information provided by _________________________ in this marketing plan is confidential; therefore, reader agrees not to dis...
  • pjay011 published this 11 / 14 / 2008
  • 134 reads
  • 0 comments
105 p.
Add to your reading list

Health and Human Services: MASTER%20CMS-2238-FC 070507%200406pm

Tuesday, July 17, 2007 Part II Department of Health and Human Services Centers for Medicare & Medicaid Services 42 CFR Part 447 Medicaid Program; Prescription Drugs; Final Rule rfrederick on PRO...
  • HHS published this 01 / 30 / 2008
  • 83 reads
  • 0 comments
105 p.
Add to your reading list

Rule: Medicaid: Prescription drugs; average manufacturer price

Rule: Medicaid: Prescription drugs; average manufacturer price, 39142-39245 [07-3356] Centers for Medicare & Medicaid Services
  • justia published this 05 / 01 / 2008
  • 238 reads
  • 0 comments